Resources
41 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 6/3/2021 (updated 4/10/2024)
During this session, TELs reviewed the Cohort specific sustainability template and answer questions from grantees ahead of the HRSA due dates in the fall.
Posted 5/26/2021 (updated 4/10/2024)
Opioid dependence is a chronic relapsing disorder with considerable individual and global public health burden. The current standard of care for opioid dependence includes treatment with methadone or sublingual (SL) buprenorphine or buprenorphine-naloxone (hereafter, buprenorphine), combined with psychosocial and behavioral support. Both medications are associated with reductions in mortality, illicit opioid use, bloodborne viral infections, and criminal behavior as well as better cost-effectiveness than no treatment or psychosocial treatment alone. Buprenorphine is a partial μ-opioid receptor agonist, enabling office-based treatment for nonsupervised or take-home use of the medication. However, SL formulations of buprenorphine are prone to nonmedical use (eg, injecting, diversion), prompting models of care, particularly in the early phases of treatment, requiring regular attendance at clinics or pharmacies for administration of doses.
Posted 5/25/2021 (updated 4/10/2024)
This webinar will introduce grantees to the RCORP evaluation portal and review how various data and charts can inform sustainability strategies.
Learning objectives:
Learn how to access and utilize the RCORP evaluation portal
Understand what data in the portal can inform sustainability strategies
Posted 12/23/2020 (updated 4/4/2024)
This technical package provides evidence of the effectiveness of strategies and approaches for supporting successful planning, design, implementation, and sustainability of syringe services programs (SSPs). It provides a broad framework for new and existing SSPs to ensure needs-based service delivery, reduce harms related to injection drug use, and link participants to services that support their health and wellness.
Posted 3/29/2024 (updated 4/4/2024)
This session offered a review of the programmatic work of the Foundation for Opioid Response Efforts (FORE), discussed different types of funding opportunities, and then used FORE’s application process as an example of applying for and receiving funding from private foundations.
Posted 3/28/2024 (updated 4/4/2024)
This session outlined how the Communities of Practice for Rural Communities Opioid Response Program (COP-RCORP) Consortium created a Disparities Impact Statement (DIS) that encompassed four Ohio counties (Ashtabula, Fairfield, Sandusky, and Seneca) and three HRSA grants (two RCORP-Psychostimulant grants and one RCORP-Behavioral Health Support grant).
Posted 9/29/2021 (updated 4/3/2024)
In this re-welcome session, HRSA Project Officers shared reminders and updates about grant deliverables, the Evaluation Team will gave updates, and Technical Expert Leads discussed new and ongoing technical assistance available to Implementation I, Implementation II and MAT-Expansion grantees.
Posted 11/11/2021 (updated 4/3/2024)
This session provided participants with realistic and achievable steps to help consortiums leverage their RCORP-Planning efforts to achieve long-lasting sustainable impact. Participants heard from two RCORP-Planning III sites that are successfully navigating and securing sustainability for their communities using different approaches.
Posted 11/9/2021 (updated 4/3/2024)
This workshop will explore the link between Adverse Childhood Experiences (ACEs) of individuals with substance use concerns and its impact on their development. We will explore the experiences, perceptions, beliefs, and behaviors that may present challenges in development. We will discuss practical, trauma-informed, outcome-driven strategies that improve the outcomes.